Appili Therapeutics Inc. (OTCMKTS:APLIF – Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 67,600 shares, a growth of 37.4% from the September 15th total of 49,200 shares. Based on an average daily trading volume, of 1,684,100 […]
Appili Therapeutics Inc. (OTCMKTS:APLIF – Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 49,200 shares, a drop of 53.7% from the August 15th total of 106,200 shares. Based on an average daily volume of 281,500 shares, […]
Appili Therapeutics (OTCMKTS:APLIF – Get Rating) and Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Risk & Volatility Appili Therapeutics has a beta of […]